Editas Medicine (EDIT) stock Forecast for 2022 – 2026

Editas Medicine (EDIT) stock Forecast for 2022 – 2026

Last update: 05-24-2022, 6:21

Sector: Healthcare

The share price of Editas Medicine, Inc. (EDIT) now

What analysts predict:: $32.38

52-week high/low: $73.03 / $9.71

50/200 Day Moving Average: $15.68 / $31.3

This figure corresponds to the average price over the previous 50/200 days. For Editas Medicine stocks, the 50-day moving average is the resistance level today.

For Editas Medicine stocks, the 200-day moving average is the resistance level today.

Are you interested in Editas Medicine, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Editas Medicine stock price in 2022, 2023, 2024, 2025, 2026. How much will one Editas Medicine share be worth in 2022 - 2026?

When should I take profit in Editas Medicine stock? When should I record a loss on Editas Medicine stock? What are analysts' forecasts for Editas Medicine stock? What is the future of Editas Medicine stock?

We forecast Editas Medicine stock performance using neural networks based on historical data on Editas Medicine stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Editas Medicine stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Editas Medicine shares. This happens once a day.




Historical and forecast chart of Editas Medicine stock

The chart below shows the historical price of Editas Medicine stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Editas Medicine stock price can be found in the table below.

Long-term forecasts by years.

Editas Medicine daily forecast for a month

Date Target Pes. Opt. Vol., %
May 26 11.23 11.03 11.58 4.95
May 27 10.95 10.82 11.11 2.67
May 28 10.78 10.62 11.01 3.65
May 29 10.22 9.93 10.44 5.19
May 30 10.48 10.27 10.92 6.37
May 31 10.74 10.30 11.08 7.57
Jun 01 10.42 9.95 10.88 9.30
Jun 02 10.17 9.71 10.64 9.62
Jun 03 9.73 9.35 10.12 8.30
Jun 04 9.23 9.12 9.62 5.47
Jun 05 9.40 9.26 9.80 5.78
Jun 06 9.79 9.50 10.21 7.55
Jun 07 9.85 9.55 10.28 7.67
Jun 08 9.96 9.57 10.31 7.80
Jun 09 9.76 9.49 9.92 4.44
Jun 10 10.16 9.77 10.62 8.74
Jun 11 10.24 9.90 10.63 7.38
Jun 12 10.71 10.25 11.09 8.22
Jun 13 10.83 10.40 11.35 9.12
Jun 14 10.56 10.14 10.72 5.69
Jun 15 10.50 10.03 10.91 8.80
Jun 16 10.07 9.62 10.45 8.60
Jun 17 10.33 10.02 10.75 7.30
Jun 18 10.16 9.84 10.54 7.12
Jun 19 10.27 9.81 10.58 7.79
Jun 20 10.89 10.71 11.35 6.04
Jun 21 10.46 10.03 10.96 9.26
Jun 22 9.94 9.59 10.31 7.59
Jun 23 9.43 9.17 9.73 6.17
Jun 24 9.04 8.85 9.16 3.56

Editas Medicine Daily Price Targets


Editas Medicine Stock Forecast 05-26-2022.

Forecast target price for 05-26-2022: $11.23. Positive dynamics for Editas Medicine shares will prevail with possible volatility of 4.715%.

Pessimistic target level: 11.03

Optimistic target level: 11.58


Editas Medicine Stock Forecast 05-27-2022.

Forecast target price for 05-27-2022: $10.95. Negative dynamics for Editas Medicine shares will prevail with possible volatility of 2.603%.

Pessimistic target level: 10.82

Optimistic target level: 11.11


Editas Medicine Stock Forecast 05-28-2022.

Forecast target price for 05-28-2022: $10.78. Negative dynamics for Editas Medicine shares will prevail with possible volatility of 3.526%.

Pessimistic target level: 10.62

Optimistic target level: 11.01


Editas Medicine Stock Forecast 05-29-2022.

Forecast target price for 05-29-2022: $10.22. Negative dynamics for Editas Medicine shares will prevail with possible volatility of 4.930%.

Pessimistic target level: 9.93

Optimistic target level: 10.44


Editas Medicine Stock Forecast 05-30-2022.

Forecast target price for 05-30-2022: $10.48. Positive dynamics for Editas Medicine shares will prevail with possible volatility of 5.985%.

Pessimistic target level: 10.27

Optimistic target level: 10.92


Editas Medicine Stock Forecast 05-31-2022.

Forecast target price for 05-31-2022: $10.74. Positive dynamics for Editas Medicine shares will prevail with possible volatility of 7.037%.

Pessimistic target level: 10.30

Optimistic target level: 11.08


EDIT (EDIT) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 10.25 9.71 11.35 14.42
Jul. 10.66 9.18 11.24 18.32
Aug. 9.61 8.56 10.37 17.50
Sep. 10.62 9.57 11.42 16.20
Oct. 9.46 9.00 10.99 18.08
Nov. 9.40 8.88 10.44 14.93
Dec. 10.52 10.04 11.78 14.82

Editas Medicine forecast for this year


Editas Medicine Stock Prediction for Jun 2022

An downtrend is forecast for this month with an optimal target price of $10.2497. Pessimistic: $9.71. Optimistic: $11.35


Editas Medicine Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $10.6586. Pessimistic: $9.18. Optimistic: $11.24


Editas Medicine Stock Prediction for Aug 2022

An downtrend is forecast for this month with an optimal target price of $9.60662. Pessimistic: $8.56. Optimistic: $10.37


Editas Medicine Stock Prediction for Sep 2022

An uptrend is forecast for this month with an optimal target price of $10.6153. Pessimistic: $9.57. Optimistic: $11.42


Editas Medicine Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $9.45613. Pessimistic: $9.00. Optimistic: $10.99


Editas Medicine Stock Prediction for Nov 2022

An downtrend is forecast for this month with an optimal target price of $9.39655. Pessimistic: $8.88. Optimistic: $10.44


Editas Medicine Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $10.5213. Pessimistic: $10.04. Optimistic: $11.78




Editas Medicine (EDIT) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 11.12 10.35 12.82 19.30
Feb 12.29 11.74 13.60 13.66
Mar 11.10 10.38 12.29 15.55
Apr 9.72 9.17 10.48 12.47
May 8.60 7.79 9.68 19.58
Jun 9.32 7.93 10.81 26.62
Jul 10.58 9.95 11.22 11.28
Aug 11.80 10.93 13.41 18.48
Sep 12.76 10.67 13.33 19.91
Oct 11.88 11.16 12.48 10.60
Nov 12.35 10.90 13.21 17.48
Dec 14.92 13.67 16.02 14.67

Editas Medicine (EDIT) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 12.04 10.80 13.15 17.88
Feb 10.50 9.39 11.18 15.97
Mar 10.96 10.43 11.44 8.85
Apr 11.49 9.70 13.32 27.16
May 10.28 8.73 11.86 26.40
Jun 11.82 11.02 12.76 13.61
Jul 13.35 11.98 15.04 20.33
Aug 13.27 11.65 15.11 22.87
Sep 13.88 13.01 16.16 19.49
Oct 11.78 10.00 13.61 26.54
Nov 11.86 10.04 12.85 21.89
Dec 12.70 11.40 13.64 16.43



Editas Medicine (EDIT) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 14.36 12.76 16.05 20.48
Feb 15.32 13.94 17.19 18.91
Mar 15.29 12.88 17.73 27.35
Apr 15.23 13.72 17.21 20.25
May 16.12 13.92 17.48 20.34
Jun 16.33 14.03 18.69 24.95
Jul 16.94 15.73 17.87 11.95
Aug 19.01 15.81 20.64 23.40
Sep 16.97 14.23 18.57 23.41
Oct 16.33 15.54 17.32 10.29
Nov 15.40 12.88 16.34 21.18
Dec 14.89 12.38 17.11 27.60

Editas Medicine (EDIT) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 16.60 15.80 18.35 13.87
Feb 15.42 14.45 16.13 10.44
Mar 15.68 14.26 17.00 16.08
Apr 17.59 15.48 20.03 22.69
May 19.25 16.82 20.87 19.37
Jun 17.23 16.14 19.94 19.05
Jul 16.65 14.62 19.45 24.81
Aug 19.80 16.47 22.67 27.33
Sep 17.88 16.46 19.61 16.09
Oct 18.30 16.26 19.60 17.05
Nov 19.37 16.89 20.63 18.14
Dec 18.19 17.01 19.99 14.91

Editas Medicine information and performance

Editas Medicine is a clinical biotechnology company that develops therapies based on CRISPR gene editing technology – Cas9. Editas is based in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

Editas Medicine Address

11 HURLEY ST., CAMBRIDGE, MA, US

Market Capitalization: 745 442 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -106 383 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.73

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: 0.042

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 11.28

Enterprise Value (EV) /Revenue

EV To EBITDA: -

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 68641000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.